PipelinePharma Logo
PipelinePharma Logo

CTD Dossier Marketplace

Direct connection with CTD dossier (IP) owners and manufacturers

Marketing Authorizations Database

Search across marketing authorization registers
Sign in Get started

Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-189 manufacturers

Filters

None products found

pp-189

Tablets

Dossier type
CTD
Dossier status
Under development
Country of origin
South Korea
GMP approvals
PICS
Comments
Indication: Osteosarcoma (recurrent/refractory); multiple solid tumour indications Clinical stage: Phase 2 — for osteosarcoma (combination with pembrolizumab) Modality: Small molecule (selective kinase inhibitor) Mechanism / Target: Dual inhibitor of TGF-β type I receptor (ALK5/TGFβRI) and ALK4; blocks TGF-β-driven immunosuppression in tumour microenvironment and reduces tumour cell proliferation Route / form: Oral tablet/capsule Differentiation: First-in-class dual TGFβRI/ALK5 inhibitor; FDA Fast Track + Orphan Drug Designation for osteosarcoma; broad combination potential with checkpoint inhibitors;
Manufacturer #39329
South Korean clinical-stage company using genome-based methods to develop Rx therapeutics for cancer and autoimmune diseases. Pipeline advances novel candidates through domestic and global clinical trials in oncology and immunology therapy areas. Focused on differentiated therapies with novel mechanisms of action addressing significant unmet patient needs.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.